Date Filed | Type | Description |
05/31/2023 |
4
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns:
| Granted 5,357 shares
@ $0 Granted 22,500 options to buy
@ $11.2, valued at
$252k
|
|
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2023 |
4
| EASTLAND JULIA MARIE (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Granted 407,600 options to buy
@ $0.89, valued at
$362.8k
|
|
06/03/2022 |
4
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on GRAYBUG VISION, INC.
Txns:
| Granted 20,000 options to buy
@ $0.984, valued at
$19.7k
Granted 20,000 restricted stock units
@ $0 |
|
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/09/2021 |
4
| EASTLAND JULIA MARIE (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Granted 350,000 options to buy
@ $6.85, valued at
$2.4M
|
|
06/04/2021 |
4
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on GRAYBUG VISION, INC.
Txns:
| Granted 12,500 options to buy
@ $4.07, valued at
$50.9k
|
|
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/14/2021 |
4/A
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Granted 10,167 options to buy
@ $0 |
|
05/07/2021 |
4
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Granted 10,167 options to buy
@ $22.5, valued at
$228.8k
|
|
09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/01/2020 |
4
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Granted 10,167 options to buy
@ $20.59, valued at
$209.3k
|
|
06/05/2019 |
4
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Granted 10,167 options to buy
@ $11.84, valued at
$120.4k
|
|
03/29/2019 |
4
| EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns:
| Granted 5,907 options to buy
@ $14, valued at
$82.7k
|
|
02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/13/2018 |
4
| EASTLAND JULIA MARIE (CFO & CBO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns:
| Unknown transaction of 5,237 shares
@ $0 Disposed/sold 6,667 options to buy
@ $19.86, valued at
$132.4k
Disposed/sold 8,334 options to buy
@ $19.92, valued at
$166k
Disposed/sold 8,334 options to buy
@ $41.52, valued at
$346k
Disposed/sold 8,334 options to buy
@ $28.44, valued at
$237k
Disposed/sold 25,000 options to buy
@ $10.44, valued at
$261k
Disposed/sold 16,667 options to buy
@ $10.56, valued at
$176k
Disposed/sold 41,667 options to buy
@ $21.06, valued at
$877.5k
Disposed/sold 50,000 options to buy
@ $6.9, valued at
$345k
Disposed/sold 51,200 options to buy
@ $4.64, valued at
$237.6k
Disposed/sold 75,000 options to buy
@ $3.99, valued at
$299.3k
|
|
02/02/2018 |
4
| EASTLAND JULIA MARIE (CFO & CBO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns:
| Granted 199,000 options to buy
@ $0 |
|
01/16/2018 |
4
| EASTLAND JULIA MARIE (CFO & CBO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 923 shares
@ $3.92, valued at
$3.6k
Exercised 2,825 options to buy
@ $0 |
|
09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/05/2011 |
4
| EASTLAND JULIA MARIE (CFO & VP, CORP. DEVELOPMENT) has filed a Form 4 on Oncothyreon Inc.
Txns:
| Granted 50,000 options to buy
@ $6.92, valued at
$346k
|
|
12/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/10/2010 |
4
| EASTLAND JULIA MARIE (CFO & VP, Corp. Development) has filed a Form 4 on Oncothyreon Inc.
Txns:
| Granted 40,000 options to buy
@ $3.31, valued at
$132.4k
|
|
09/07/2010 |
3
| EASTLAND JULIA MARIE (CFO AND VP CORP DEVELOPMENT) has filed a Form 3 on Oncothyreon Inc. |